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837-5 Influence of Coronary Artery Bypass Grafting on the 
Outcome of Aortic Valve Replacement in the Presence 
of Left Ventriculsr Dysfunction: The VERDI (Valve 
Replacement With Left Ventrlcular Dysfunction Italian) 
Surgical Study 
Roberto Lorusso, Cesare Beghi, Luca Sailors, Piersilvio Gerometta, Claudio Russo, 
Vincanzo Cianci, Andrea Garatti, Elena Ribera, "Rziano Gherli, Vincenzo Arena, Ettore 
Vitali, Salvatore Casari, Gaetano Minzioni, Cardiac Surgery Unit - Ospeda/e Civi/e, 
Brescia, Italy, Cardiac Surgery Units, Parma, Bergamo, Milan, Italy. 
Background: The impact of coronary artery bypass grafting (CABG) on the results of aor- 
tic valve replacement (AVR) in the presence of left ventricular (LV) dysfunction is still 
poorly defined. This retrospective multiinstitutional study evaluated the long-term results 
of AVR with or without combined CABG in patients affected by impaired LV contractility. 
Methods: From January 1990 to December 2000, 257 patients with LV impairment (LVEF 
<40%) had undergone AVR because of aortic stenosis at 4 different Institutions. Fifty- 
nine patients (Group A) had been submitted to associated CABG, whereas 198 patients 
(Group B) had had isolated AVR. Both groups were followed-up in terms of POStoperative 
morbidity and mortality. Kaplan-Meier estimate and logistic regression multivariate analy- 
sis were performed to elucidate postoperative results and disclose predictors of 
unfavoureble late outcome, including patient/prosthesis mismatch (prosthesis size/body 
surface area). 
Results: Preoperative patient profile did not differ between the two groups, except for 
patient age (71±7 in Group A, and 68±11 in Group B -p>0.05-, respectively). Follow-up 
was 100% complete. No significant difference was found between the two groups in 
terms of late morbidity and mortality, although a trend (p:0.06) towards a worse survival 
was shown in patients submitted to AVR+CABG (75% at 5 years and 50% at 8 years in 
Group A, and 85% and 65% in Group B, respectively). Satisfactory recovery of long-term 
functional capacity was achieved in both groups. Patient/prosthesis mismatch was not a 
determinant of unfavourable outcome, whereas older age (p<0.001, hazard retio:4.08. 
C.I.: 2.05-8.13) represented the only negative predictor in both groups. 
Conclusions: CABG procedure does not appear to significantly influence postoperative 
results of AVR in the presence of LV dysfunction. However. elderly patients are at higher 
risk of unfavourable late outcome whereas patient/prosthesis mismatch does not appar- 
ently influence patient survival or recovery of patient functional capacity in this setting. 
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837-6 Initiation of AnticosgulsUon After Cardiac Surgery: A 
Prospective Cohort Study of Efficacy, Safety, and Cost 
With Low Molecular Weight Heparin Bridging in Lieu of 
Continuous Intravenous Unfractlonsted Heparin 
Kanella V. TsUimingras, Nicole Grasso-Corranti, John Fanikos. Samuel Z. Goldhaber, 
Brigham and Women's Hospital, Boston, Massachusetts, Harvard Medical School, 
Boston, Massachusetts. 
Initiation of anticoagulation after cardiac surgery often delays discharge and prolongs 
hospital stay. This problem is especially common after prosthetic heart valve surgery and 
coronary artery bypass grafting (CABG) complicated by postoperative atrial fibrillation. 
Traditionally, intravenous unfractionated hepadn and warfarin are initiated concomitantly, 
and continuous intravenous heparin is discontinued after a therapeutic International Nor- 
malized Ratio (INR) with warfarin is achieved. Our Cardiac Centar's Anticcagulation Ser- 
vice tested an altemative strategy: administration of subcutaneous low molecular weight 
heparin (LMWH) instead of intravenous unfrectionated hepadn as a "bridge" to oral anti- 
coagulation. We continued LMWH on an outpatient basis until a therapeutic INR was 
achieved. In a prospective cohort study, we enrolled 55 postoperative cardiac surgery 
patients whom we managed with enoxaparin as a 'bddge" to warfarin: 44 with prosthetic 
heart valves and 11 with CABG and postoperative atrial fibrillation. With respect to effi- 
cacy, one patient (1.8%, 95%C1=0.04% to 9.7%) suffered a small embolic stroke without 
residual neurologic dysfunction three days after hospital discharge following CABG, 
mitrel valve repair, and new onset atrial fibrillation. Two patients, one on day #1 and the 
other on day #3 after hospital discharge, (3.6%, 95%C1=0.4% to 12%) had bloody pleural 
effusions requiring thoracentesis. The strategy of enoxaparin "bridging' on an outpatient 
basis instead of administering inpatient continuous intravenous unfractionated heparin 
reduced postoperative length of hospital stay by a mean of 4.6 days (range 1-11 days). 
We calculated the cost-avoidance of the LMWH "bridging" strategy by multiplying each 
patient's daily bed occupancy cost by the number of outpatient days bridged with enox- 
aparin. Estimated savings totaled $323,300 and averaged $5,878 per patient. We con- 
clude that "bridging" with LMWH after cardiac surgery is cost-saving by reducing hospital 
length of stay. However, randomized controlled trials are required to compare the efficacy 
and safety of "bridging" versus conventional anticoagulation. 
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1155-131 Trends in Rheumatic Valvular Heart Disease: A 
Longitudinal Study of Hospitalizations in New York 
State (1983-1999) 
Phyllis G. Suoino, Jeffrey S. Borer, Sritatha Atiuri, Andrew Yin, Weill Medical College of 
Come# Universi~ New York, New York. 
Background: Acute rheumatic fever (ARF) has increased in the U.S. during the past few 
decades but the impact of ARF on subsequent R heart disease (HD) and hospitalizations 
and surgical procedures forR valvular (V) HD is unknown. Methods: For relevant 
insights, we studied records obtained from the New York State's Statewide Planning and 
Research Cooperative System (SPARCS) inpatient database for the years 1983 through 
1999. All analyzed records had either a principal or secondary diagnosis (ICD-9 code) of 
RVHD (n=255,958 cases), including aortic and/or mitral stenosis and/or insufficiency, tri- 
cuspid RVHD and (rarely) pulmonic RVHD. Linear regression was used to examine tam- 
poral variations in hospitalizations and total RVHD-relatad surgical procedures. Results: 
During the 17-year interval, hospitalizations including a RVHD diagnosis more than dou- 
bled, increasing in linear fashion from 9058 in 1983 to 18,536 in 1999. A similar, but more 
modest, trend occurred for surgery or percutansous valvuloplasty (1179 in 1983, 1632 in 
1999). Linearized rates of increase in hospitalizations and surgical procedures were 817/ 
yr (r 2 = .92, p<.001) and 37/yr (r 2 = .88, p<.001 ). The most common isolated RVHD disor- 
der was mitral stanosis; the most frequent surgical procedure was V replacement. Con- 
clusions: During the past 2 decades, hospital-based management of RVHD has 
increased strikingly in New York State. This may be due to improved detection, increased 
disease prevalence (possibly due to immigration patterns or to a fundamental change in 
disease penetration), easier accessibility of VHD therapy, or more effective VHD surgery 
increasing likelihood of hospital care. Further study must elucidate factors promoting 
increased utilization of health care resources for RVHD as well as preventive measures 
to blunt the apparently increasing disease prevalence. 
1155-132 A Proper Range of the International Normalized Ratio 
for Left Atrial Thrombi Resolution Among Candidates 
for Percutaneoue Transvenous Mitrsl Commissurotomy 
Under Oral Anticoagulant Therapy 
Sonokwan Silaruks. Bandit Thinkhamrop, Chaiyasith Wongvipaporn, Wirota Tantikosum, 
Pyatat Tatsanavivat, Virat Klungboonkrong, Khon Kaen Universi~ Khon Kaen, Thailand. 
Background: Resolution of left atrial thrombus (LAT), by orat anticoagulation (OA), in 
mitral stenosis can enhance the possibUity of safely performing pemutaneous trans- 
venous mitral commissurotomy (PTMC). However, the proper range of the international 
normalized ratio (INR) for this purpose has not been established. 
Objectives: To determine the optimal cut-off point for establishing the proper INR range 
that best predicts the LAT resolution among PTMC candidates under OA. 
Methods: From August 1996 to December 2000, all PTMC candidates with I_AT were 
given OA and serially studied by both transthorecic and transesophageal echooardio- 
graphic studies. For the INR, most patients were monitored to be within the range of rou- 
tine cardiology practice (2.0 to 3.0), whereas others were adjusted as they could tolerate. 
Cox proportional hazard model was used to determine the effect of INR adjusted for 
other potential confounders. Receiver Operating Characteristics (ROC) curve was 
applied to identify an optimal INR cut-off point. 
Results: A total of 134 PTMC candidates with LAT (mean age 40.2 ± 7.6) were followed- 
up for 6-48 months (mean 20.5 ± 6.2). Of 1791 patient-months studied, 85 patients (4.7/ 
100 patient-months) demonstrated resolution of I_AT. Of 606 INR samples, the mean of 
the median of INR was 3.0 ± 0.2 (range 2.3 to 3.5) in the LAT-resolution group (333 INR 
samples, 89.2% exceeded 2.5) and 2.2 ± 0.1 (range 1.7 to 2.5) in the LAT-persisting 
group (273 INR samples, 10.9% exceeded 2.5). The INR almost completely predicted 
the LAT resolution (area under ROC = 0.997; 95%Ch 0.992 to 1.0). The optimal INR cut- 
off point was 2.5, establishing the INR range of 1.7 to 2.4 and 2.5 to 33. This cut-off point 
yields the highest performance of such prediction, with the sensitivity 98%, the specificity 
100%, and the positive and negative predictive values 100% and 96%, respectively. 
Eighteen (1.0/100 patient-months) minor bleeding events were observed. No major 
bleeding was found. Transient ischemic attack occurred in one patient whose median 
INR was 2.1. 
Conclusion: The INR of 2.5 to 3.5 should be recommended as the proper range for suc- 
cassful LAT resolution among candidates for PTMC under OA, with low bleeding compli- 
cations. 
